Table 1.
Baseline patient characteristics of an esophageal cancer cohort (n = 134) at Columbia University and Weill Cornell Medical Centers (2009–2015)
| Age at diagnosis, mean (SD) | 64.5 (11.1) |
| Sex, male (%) | 109 (81.3%) |
| Race, white (%) | 119 (88.8%) |
| Ethnicity, non-Hispanic (%) | 119 (88.8%) |
| Tobacco exposure (%) | |
| Never | 35 (26.1%) |
| Former | 75 (66.0%) |
| Current | 24 (17.9%) |
| Charlson comorbidity index, median (IQR)† | 1 (0–1) |
| Charlson comorbidity index (%)‡ | |
| 0 | 66 (49.6) |
| 1 | 36 (27.1) |
| 2 | 14 (10.5) |
| 3 or greater | 17 (12.8) |
| BMI at diagnosis, median (IQR) | 26.4 (23.4–29.4) |
| BMI one year prior, median (IQR) | 28.3 (24.4–31.0) |
| BMI, one year prior (%) | |
| Underweight (15–20) | 9 (6.7%) |
| Normal (>20–25) | 29 (21.6%) |
| Overweight (>25–30) | 54 (40.3%) |
| Obese (>30) | 42 (31.3%) |
| Weight loss in pounds, median (IQR) | 10 (0 - 20) |
| Weight loss (%) | |
| No weight loss | 39 (29.1%) |
| >0, <5% | 31 (23.1%) |
| ≥5, <10% | 28 (20.9%) |
| ≥10% | 36 (26.9%) |
†
Esophageal cancer was excluded from Charlson comorbidity index score.
‡
Data missing in 1 individual.
BMI, body mass index; IQR, interquartile range; SD, standard deviation.